Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

does-iradimed’s-new-bullish-analyst-coverage-reframe-its-mri-pump-story-or-just-test-sentiment-(irmd)?

Does IRadimed’s New Bullish Analyst Coverage Reframe Its MRI Pump Story Or Just Test Sentiment (IRMD)?

Apr 5, 2026

In recent days, Freedom Capital Markets analyst Ilya Zubkov initiated coverage on IRadimed (IRMD.US) with a buy rating,…

Read more
caci-international-stock-rises-following-wells-fargo-overweight-initiation

CACI International Stock Rises Following Wells Fargo Overweight Initiation

Apr 4, 2026

Apr 3, 2026 According to a report from Yahoo Finance, shares of CACI International increased in afternoon trading.…

Read more
singular-research-initiates-coverage-on-virtuix-holdings-inc.-(vtix)

Singular Research Initiates Coverage on Virtuix Holdings Inc. (VTIX)

Apr 4, 2026

Los Angeles, California–(Newsfile Corp. – April 1, 2026) – Singular Research, a leading independent boutique research firm, has…

Read more
astec-industries-(aste)-is-up-5.6%-after-q4-beat-and-bullish-analyst-initiation

Astec Industries (ASTE) Is Up 5.6% After Q4 Beat And Bullish Analyst Initiation

Apr 4, 2026

In recent weeks, Freedom Capital Markets initiated coverage on Astec Industries with a buy rating, while the company…

Read more
wolfe-research-initiates-coverage-of-beone-medicines-ag-(onc)-with-outperform-rating

Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating

Apr 4, 2026

Jeff Lewis Sat, April 4, 2026 at 8:17 AM EDT 1 min read BeOne Medicines AG (NASDAQ:ONC) is…

Read more
assessing-group-1-automotive-(gpi)-valuation-after-fresh-positive-analyst-coverage-and-upgrade-to-buy

Assessing Group 1 Automotive (GPI) Valuation After Fresh Positive Analyst Coverage And Upgrade To Buy

Apr 4, 2026

Why recent analyst calls are putting Group 1 Automotive in focus Group 1 Automotive (GPI) is back on…

Read more
nutanix-(ntnx)-stock-surges-as-analyst-coverage-kicks-off-with-strong-buy

Nutanix (NTNX) Stock Surges as Analyst Coverage Kicks Off With Strong-Buy

Apr 4, 2026

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com TLDR Rosenblatt Securities initiated coverage of…

Read more
coreweave-analyst-ratings-and-price-targets-|-nasdaq:crwv

CoreWeave Analyst Ratings and Price Targets | NASDAQ:CRWV

Apr 4, 2026

España Italia 대한민국 日本 Français Benzinga Edge Benzinga Research Benzinga Pro Get Benzinga Pro Data & APIs Events…

Read more
nutanix-(ntnx)-stock-surges-as-analyst-coverage-kicks-off-with-strong-buy

Nutanix (NTNX) Stock Surges as Analyst Coverage Kicks Off With Strong-Buy

Apr 4, 2026

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com TLDR Rosenblatt Securities initiated coverage of…

Read more
a-look-at-equinix-(eqix)-valuation-after-fresh-analyst-coverage-and-ai-infrastructure-growth-expectations

A Look At Equinix (EQIX) Valuation After Fresh Analyst Coverage And AI Infrastructure Growth Expectations

Apr 3, 2026

Fresh analyst coverage has put Equinix (EQIX) back in focus, as research firms highlight its global data center…

Read more
nutanix-(ntnx)-stock-soars-8%-following-bullish-analyst-initiation

Nutanix (NTNX) Stock Soars 8% Following Bullish Analyst Initiation

Apr 3, 2026

Key Highlights Rosenblatt Securities launched coverage on Nutanix (NTNX) with a “Strong-Buy” designation and established a $60 price…

Read more
mbx-biosciences-(mbx)-is-up-16.6%-after-analyst-initiation-and-leadership-award-news-has-the-bull-case-changed?

MBX Biosciences (MBX) Is Up 16.6% After Analyst Initiation And Leadership Award News Has The Bull Case Changed?

Apr 3, 2026

In recent days, MBX Biosciences drew attention as LifeSci Capital initiated coverage and traders reacted to a technical…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 8
  6. 9
  7. 10
  8. 11
  9. 12
  10. 13
  11. 14
  12. ...
  13. 394
  14. »

Posts pagination

Newer posts Page 1 … Page 11 … Page 394 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.